Artemis Medicare Services Limited has informed the Exchange regarding a press release dated February 02, 2026, titled "Artemis Consolidated Revenue from Operations up 17.2% in Q3 (YoY); EBITDA up 12.5%; Net Profit up 7.9%".
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services reported its Q3 FY2026 consolidated results, with revenue from operations rising 17.2% year-on-year. EBITDA grew 12.5%, while net profit increased 7.9% over the same period. The slower growth in EBITDA and net profit compared to revenue suggests some margin pressure despite top-line expansion. The company shared these figures through a press release dated February 2, 2026, submitted to the exchange.
Solid revenue growth signals healthy demand for Artemis's hospital services, but the divergence between revenue growth (17.2%) and profit growth (7.9%) points to rising costs or margin compression, which investors should watch closely in upcoming quarters.